Author Archives: eggalph

The Leadership of the National Institute of Allergy and Infectious Disease (NIAD) recently published a comment in the Nature titled: “The new vision from the National Institute of Allergy and Infectious Diseases (NIAID).” In the article, NIAID leadership introduced two new strategic aims: (1) Support research to address important challenges in...

Join the UNC CFAR for the March CFAR-Wide Webinar with Dr. Geri Donenberg. Geri R. Donenberg, Ph.D., is the Associate Director for AIDS Research and Director of the Office of AIDS Research (OAR) at the National Institutes of Health (NIH). Working in close collaboration with NIH Institutes and Centers, Dr....

Early registration for AIDS 2026 ends today, February 12. The Conference will take place July 26-31, 2026 in Rio de Janeiro, Brazil and virtually. This year’s theme will be Rethink. Rebuild. Rise. At a pivotal moment for HIV research and response—marked by unprecedented funding cuts and disruptions to HIV programs—the...

Join the UNC CFAR and the NIH in honoring National Black HIV/AIDS Awareness Day on February 7th! Since 1999, this day has highlighted the importance of community engagement and improved access to HIV education, prevention, testing, and treatment services. While progress have been made in the areas of prevention, care,...

Respond Carolinas is a community‑centered initiative aimed at improving HIV prevention, testing, and care engagement among Black and Latino men and transgender women in Charlotte, NC, and the surrounding area. The project is led by Ann Dennis, MD, MS, the principal investigator and an associate professor of infectious diseases at...

A phase 2 study, published in Annals of Internal Medicine and led by Joe Eron, MD, Director of the CFAR Clinical Core, found that a new once-weekly oral HIV treatment regimen achieved virologic suppression through 48 weeks. The study evaluated the efficacy and safety of once-weekly oral islatravir plus lenacapavir...

The AIDS Clinical Trials Group (ACTG) has begun the IPACE-HIV study (Improving Physical Ability and Cellular Senescence Elimination in HIV). IPACE-HIV aims to evaluate the safety, tolerability, and efficacy of dasatinib and quercetin, medications that can help with reversing symptoms of frailty, in people living with HIV (PLWH), as well...

UNC CFAR SBIS Core Director Vivian Go and Developmental Core Co-Director Bill Miller recently published the findings from their hybrid type 3 implementation-effectiveness, cluster-randomized trial in ten provinces in Vietnam. This study, conducted with a team from UNC Vietnam, Hanoi Medical University, and the Vietnam Ministry of Health, aimed to...

Congratulations to the UNC Institute for Global Health and Infectious Diseases for being awarded an ID STEP (Infectious Disease Structured Training and Engagement Program) grant. This grant will be used to develop a program for medical students to expand equitable access to infectious disease expertise for folks living in North...

The UNC CFAR congratulates the Malawi HIV Implementation Research Scientist Training (M-HIRST) program, which was competitively renewed with partners at Kamuzu University of Health Sciences (KUHeS). This program is funded by the Fogarty International Center at the U.S. National Institutes of Health (NIH). The M-HIRST program will continue to strengthen...

When we ask the client what matters most to them, it can be a good way to continue building rapport. This conversation can explore what the client really cares about and how these goals and values may guide their lives. And we also know that goals and values are aspirations,...